(Press-News.org) https://doi.org/10.1016/j.apsb.2025.04.018
This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells.
Chemotherapy is currently the mainstay of systemic management for triple-negative breast cancer (TNBC), but chemoresistance significantly impacts patient outcomes.
This research indicates that Doxorubicin (Dox)-resistant TNBC cells exhibit increased glycolysis and ATP generation compared to their parental cells, with this metabolic shift contributing to chemoresistance. It was discovered that ALKBH3, an m1A demethylase enzyme, is crucial in regulating the enhanced glycolysis in Dox-resistant TNBC cells.
Knocking down ALKBH3 reduced ATP generation, glucose consumption, and lactate production, implicating its involvement in mediating glycolysis. Further investigation revealed that aldolase A (ALDOA), a key enzyme in glycolysis, is a downstream target of ALKBH3. ALKBH3 regulates ALDOA mRNA stability through m1A demethylation at the 3′-untranslated region (3′UTR). This methylation negatively affects ALDOA mRNA stability by recruiting the YTHDF2/PAN2–PAN3 complex, leading to mRNA degradation. The ALKBH3/ALDOA axis promotes Dox resistance both in vitro and in vivo.
Clinical analysis demonstrated that ALKBH3 and ALDOA are upregulated in breast cancer tissues, and higher expression of these proteins is associated with reduced overall survival in TNBC patients. This study highlights the role of the ALKBH3/ALDOA axis in contributing to Dox resistance in TNBC cells through regulation of ALDOA mRNA stability and glycolysis.
Keywords: Glycolysis, Chemoresistance, ALKBH3, m1A, ALDOA, Stability, TNBC, 3′UTR
Graphical Abstract: available at https://ars.els-cdn.com/content/image/1-s2.0-S2211383525002758-ga1_lrg.jpg
This study reports that ALKBH3 regulates glycolysis in doxorubicin-resistant TNBC cells through m1A methylation of ALDOA mRNA. Specifically, m1A methylation negatively regulated ALDOA mRNA stability by recruiting the YTHDF2/PAN2–PAN3 complex.
# # # # # #
The Journal of the Institute of Materia Medica, the Chinese Academy of Medical Sciences and the Chinese Pharmaceutical Association.
For more information please visit https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/
Editorial Board: https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b/editorial-board
APSB is available on ScienceDirect (https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b).
Submissions to APSB may be made using Editorial Manager® (https://www.editorialmanager.com/apsb/default.aspx).
CiteScore: 24.3
Impact Factor: 14.6 (Top 6 journal in the category of Pharmacology and pharmacy)
JIF without self-citation: 13.8
ISSN 2211-3835
# # # # #
Yuhua Deng, Zhiyan Chen, Peixian Chen, Yaming Xiong, Chuling Zhang, Qiuyuan Wu, Huiqi Huang, Shuqing Yang, Kun Zhang, Tiancheng He, Wei Li, Guolin Ye, Wei Luo, Hongsheng Wang, Dan Zhou, ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells, Acta Pharmaceutica Sinica B, Volume 15, Issue 6, 2025, Pages 3092-3106, ISSN 2211-3835, https://doi.org/10.1016/j.apsb.2025.04.018
END
https://doi.org/10.1016/j.apsb.2025.04.007
This new article publication from Acta Pharmaceutica Sinica B, discusses how a photodynamic nanohybrid system reverses hypoxia and augments anti-primary and metastatic tumor efficacy of immunotherapy.
Photodynamic immunotherapy is a promising strategy for cancer treatment. However, the dysfunctional tumor vasculature results in tumor hypoxia and the low efficiency of drug delivery, which in turn restricts the anticancer effect of photodynamic immunotherapy.
The ...
https://www.sciencedirect.com/journal/acta-pharmaceutica-sinica-b/vol/15/issue/6
Acta Pharmaceutica Sinica B (APSB) was founded with the goal of creating a global high-level forum centred around drug discovery and pharmaceutical research/application. APSB was included by Chemical Abstracts in 2011, accepted by PubMed Central in 2015, indexed by Science Citation Index in 2017 and has evolved to become one of the most important international journals in the field of pharmaceutical sciences.
APSB is a monthly journal, in English, which publishes ...
LA JOLLA (July 9, 2025)—Pain isn’t just a physical sensation—it also carries emotional weight. That distress, anguish, and anxiety can turn a fleeting injury into long-term suffering.
Researchers at the Salk Institute have now identified a brain circuit that gives physical pain its emotional tone, revealing a new potential target for treating chronic and affective pain conditions such as fibromyalgia, migraine, and post-traumatic stress disorder (PTSD).
Published on July 9, 2025, in Proceedings of the National Academy of Sciences, the study identifies a group of neurons in a central brain area called the thalamus ...
The graphite found in your favorite pencil could have instead been the diamond your mother always wears. What made the difference? Researchers are finding out.
How molten carbon crystallizes into either graphite or diamond is relevant to planetary science, materials manufacturing and nuclear fusion research. However, this moment of crystallization is difficult to study experimentally because it happens very rapidly and under extreme conditions.
In a new study published July 9 in Nature Communications, researchers from the University of California, Davis and George Washington ...
Scientists have used ultracold atoms to successfully demonstrate a groundbreaking method of particle acceleration that could unlock new understanding of how cosmic rays behave, a new study reveals.
After more than 70 years from its formulation, researchers have observed the Fermi acceleration mechanism in a laboratory by colliding ultracold atoms against engineered movable potential barriers – delivering a significant milestone in high-energy astrophysics and beyond.
Fermi acceleration is the mechanism responsible for the generation of cosmic rays, as postulated by physicist Enrico Fermi in 1949. ...
ACM, the Association for Computing Machinery, is pleased to announce a new journal, ACM AI Letters (AILET), a unique venue for rapid publication of impactful, concise, and timely communications in artificial intelligence. In keeping with ACM’s broader goals, all AILET papers will be open access, with no publication charges for the first three years. ACM AI Letters will open for submissions in summer 2025.
Bridging a crucial gap between traditional conferences and journals, AILET will feature short peer-reviewed contributions that accelerate knowledge dissemination across academia and industry. This unique publication prioritizes theoretical breakthroughs, algorithmic ...
In a new study published in the European Heart Journal, researchers reported the successful development and validation of a medical artificial intelligence (AI) model that screens for cardiac amyloidosis, a progressive and irreversible type of heart disease.
The results showed that the AI tool is highly accurate, outperforming existing methods and potentially enabling earlier, more accurate diagnoses so patients can benefit from getting the right treatment sooner.
What is cardiac amyloidosis?
Cardiac amyloidosis is a heart condition in which abnormal proteins ...
Loneliness is common and is a strong and independent predictor of depression and poor health outcomes, according to a new study published July 9, 2025 in the open-access journal PLOS One by Dr. Oluwasegun Akinyemi, a Senior Research Fellow at the Howard University College of Medicine, Washington DC, U.S.
Loneliness has emerged as a significant public health concern in the United States, with profound implications for mental and physical health. In the new study, researchers analyzed Behavioral Risk Factor Surveillance System data collected via phone surveys between 2016 and 2023. The study population included 47,318 non-institutionalized adults living in the U.S., predominantly ...
Excitons – bound pairs of electrons and electron hole – are quasiparticles that can arise in solids. While so-called “bright” excitons emit light and are therefore accessible, dark excitons are optically inactive. As a result, they have a significantly longer lifetime – which makes them ideal for storing and controlling quantum states and using them for advanced methods to generate entanglement.
Gregor Weihs and his team from the Department of Experimental Physics at the University of Innsbruck, together with researchers in Dortmund, ...
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, by using drugs already approved by the FDA for unrelated conditions.
The study was published today in Science Advances.
Their research suggests that repurposing existing medications can reduce harmful immune responses associated with nanoparticles. These ultra-small particles are designed ...
